Inno PeptidesMOTS-c
Ordered MOTS-c from Inno Peptides? Mail in a sample (US only) and let us test it.
Test my supplyInno Peptides' purity-focus record is broad and recent, with stronger signals in GHK-Cu and Tirzepatide after late rebounds, plus BPC-157 identity/purity strength despite fill spread. Retatrutide is volatile after September purity misses, while Tesamorelin and MOTS-c pull weaker; batch IDs are mixed and low-volume peptides remain uncertain.
Corporate archives tie Inno Peptides to a Wuhan chemical-export network, while domain records show a renewed but parked storefront and continuing DM sales. The report separates it from the similarly named InnoPeptide and traces counterfeit-HGH, impersonation, and payment-recourse signals.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Inno Peptides rows.
Cancel anytime
About Inno Peptides test results from Finnrick
Inno Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 71 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Inno Peptides peptides in this dataset are BPC-157 (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 71 recent tests.
Ordered MOTS-c from Inno Peptides? Mail in a sample (US only) and let us test it.
Test my supply